feed,title,long_url,short_url
Investors,Why Cytokinetics CEO Is Optimistic As FDA Deadline On Aficamten Looms,https://www.investors.com/news/technology/cytokinetics-ceo-robert-blum-fda-decision-aficamten-ohcm/,
